Variables | Univariable | Multivariable | ||
---|---|---|---|---|
OR (95% CI) | p-value | OR (95% CI) | p-value | |
Age (years) | Â | Â | Â | Â |
 > 50 | Ref. |  | Ref. |  |
 ≤ 50 | 0.78 (0.52–1.17) | 0.234 | 1.01 (0.58–1.76) | 0.964 |
Palpable mass or bloody nipple discharge | Â | Â | Â | Â |
 No | Ref. |  | Ref. |  |
 Yes | 2.67 (1.76–4.05) | < 0.001 | 2.76 (1.64–4.64) | < 0.001 |
Clinical tumor size, median (range), cm | 1.26 (1.14–1.39) | < 0.001 | 1.20 (1.06–1.35) | 0.003 |
Suspicious axillary lymph node on radiologic evaluation | Â | Â | Â | Â |
 No | Ref. |  | Ref. |  |
 Yes | 2.31 (1.43–3.74) | 0.001 | 2.01 (1.08–3.74) | 0.028 |
Suspicious microcalcification on radiologic evaluation | Â | Â | Â | Â |
 No | Ref. |  | Ref. |  |
 Yes | 1.27 (0.81–1.97) | 0.296 | 1.43 (0.79–2.58) | 0.232 |
Nuclear grade*,†|  | 0.042 |  | 0.270 |
 Low | Ref. |  | Ref. |  |
 Intermediate | 1.20 (0.64–2.27) | 0.566 | 0.72 (0.31–1.68) | 0.454 |
 High | 2.16 (1.07–4.36) | 0.032 | 1.21 (0.42–3.46) | 0.720 |
Comedo necrosis*,†|  |  |  |  |
 No | Ref. |  | Ref. |  |
 Yes | 1.42 (0.88–2.29) | 0.153 | 0.86 (0.45–1.66) | 0.662 |
Hormone receptor§ |  |  |  |  |
 Negative | Ref. |  | Ref. |  |
 Positive | 0.50 (0.31–0.79) | 0.003 | 0.69 (0.31–1.54) | 0.368 |
HER2§ |  |  |  |  |
 Negative | Ref. |  | Ref. |  |
 Positive | 1.44 (0.94–2.22) | 0.093 | 0.69 (0.32–1.46) | 0.326 |
Ki-67 (%) § |  |  |  |  |
 < 14% | Ref. |  | Ref. |  |
 ≥ 14% | 2.45 (1.55–3.88) | < 0.001 | 1.55 (0.82–2.93) | 0.182 |